Skip to main content

Table 2 Summary of MR features per mRNA-based subgroup

From: Radiogenomics correlation between MR imaging features and mRNA-based subtypes in lower-grade glioma

 

R1

R2

R3

R4

Negative

Positive

Negative

Positive

Negative

Positive

Negative

Positive

Necrosis/cystic

Negative

25 (24.04)

5 (12.2)

16 (15.24)

14 (35)

29 (23.02)

1 (5.26)

20 (20)

10 (22.22)

Positive

79 (75.96)

36 (87.8)

89 (84.76)

26 (65)

97 (76.98)

18 (94.74)

80 (80)

35 (77.78)

Multifocality

Negative

97 (93.27)

41 (100)

104 (99.05)

34 (85)

119 (94.44)

19 (100)

94 (94)

44 (97.78)

Positive

7 (6.73)

0 (0)

1 (0.95)

6 (15)

7 (5.56)

0 (0)

6 (6)

1 (2.22)

Hemorrhage

Negative

86 (82.69)

38 (92.68)

90 (85.71)

34 (85)

114 (90.48)

10 (52.63)

82 (82)

42 (93.33)

 

Positive

18 (17.31)

3 (7.32)

15 (14.29)

6 (15)

12 (9.52)

9 (47.37)

18 (18)

3 (6.67)

Degree of enhancement

Negative

38 (39.18)

20 (50)

52 (52.53)

6 (15.79)

51 (43.22)

7 (36.84)

33 (34.02)

25 (62.5)

 

Positive

59 (60.82)

20 (50)

47 (47.47)

32 (84.21)

67 (56.78)

12 (63.16)

64 (65.98)

15 (37.5)

Proportion CE Tumor

Negative

59 (60.82)

31 (77.5)

79 (79.8)

11 (28.95)

78 (66.1)

12 (63.16)

54 (55.67)

36 (90)

 

Positive

38 (39.18)

9 (22.5)

20 (20.2)

27 (71.05)

40 (33.9)

7 (36.84)

43 (44.33)

4 (10)

Enhancing Margin

Well-defined

33 (34.02)

2 (5)

23 (23.23)

12 (31.58)

29 (24.58)

6 (31.58)

20 (20.62)

15 (37.5)

 

Poorly-defined

64 (65.98)

38 (95)

76 (76.77)

26 (68.42)

89 (75.42)

13 (68.42)

77 (79.38)

25 (62.5)

Extranodular Growth

Negative

73 (75.26)

38 (95)

89 (89.9)

22 (57.89)

97 (82.2)

14 (73.68)

74 (76.29)

37 (92.5)

 

Positive

24 (24.74)

2 (5)

10 (10.1)

16 (42.11)

21 (17.8)

5 (26.32)

23 (23.71)

3 (7.5)

T1 + C/T2 Mismatch

Negative

76 (78.35)

39 (97.5)

89 (89.9)

26 (68.42)

102 (86.44)

13 (68.42)

78 (80.41)

37 (92.5)

 

Positive

21 (21.65)

1 (2.5)

10 (10.1)

12 (31.58)

16 (13.56)

6 (31.58)

19 (19.59)

3 (7.5)

CS

> 30 mm

47 (46.53)

24 (58.54)

52 (50)

19 (50)

63 (51.22)

8 (42.11)

51 (52.04)

20 (45.45)

 

<=30 mm

54 (53.47)

17 (41.46)

52 (50)

19 (50)

60 (48.78)

11 (57.89)

47 (47.96)

24 (54.55)

Location

Other

65 (62.5)

24 (58.54)

60 (57.14)

29 (72.5)

81 (64.29)

8 (42.11)

61 (61)

28 (62.22)

 

Frontal lobe

39 (37.5)

17 (41.46)

45 (42.86)

11 (27.5)

45 (35.71)

11 (57.89)

39 (39)

17 (37.78)

SVZ

Negative

40 (38.46)

16 (39.02)

41 (39.05)

15 (37.5)

48 (38.1)

8 (42.11)

39 (39)

17 (37.78)

 

Positive

64 (61.54)

25 (60.98)

64 (60.95)

25 (62.5)

78 (61.9)

11 (57.89)

61 (61)

28 (62.22)

Volume

<60cm3

38 (36.54)

8 (19.51)

28 (26.67)

18 (45)

41 (32.54)

5 (26.32)

31 (31)

15 (33.33)

 

> = 60 cm3

66 (63.46)

33 (80.49)

77 (73.33)

22 (55)

85 (67.46)

14 (73.68)

69 (69)

30 (66.67)

Intratumoral vascular

Negative

1 (1.03)

2 (5)

2 (2.02)

1 (2.63)

3 (2.54)

0 (0)

3 (3.09)

0 (0)

 

Positive

96 (98.97)

38 (95)

97 (97.98)

37 (97.37)

115 (97.46)

19 (100)

94 (96.91)

40 (100)

Length

<median

57 (54.81)

19 (46.34)

54 (51.43)

22 (55)

66 (52.38)

10 (52.63)

51 (51)

25 (55.56)

 

> = median

47 (45.19)

22 (53.66)

51 (48.57)

18 (45)

60 (47.62)

9 (47.37)

49 (49)

20 (44.44)

Width

<median

58 (55.77)

16 (39.02)

50 (47.62)

24 (60)

64 (50.79)

10 (52.63)

50 (50)

24 (53.33)

 

> = median

46 (44.23)

25 (60.98)

55 (52.38)

16 (40)

62 (49.21)

9 (47.37)

50 (50)

21 (46.67)

Depth

<median

58 (55.77)

18 (43.9)

49 (46.67)

27 (67.5)

68 (53.97)

8 (42.11)

53 (53)

23 (51.11)

 

> = median

46 (44.23)

23 (56.1)

56 (53.33)

13 (32.5)

58 (46.03)

11 (57.89)

47 (47)

22 (48.89)

Length-Width Ratio

<median

56 (53.85)

21 (51.22)

54 (51.43)

23 (57.5)

66 (52.38)

11 (57.89)

55 (55)

22 (48.89)

 

> = median

48 (46.15)

20 (48.78)

51 (48.57)

17 (42.5)

60 (47.62)

8 (42.11)

45 (45)

23 (51.11)

Length-Depth Ratio

<median

53 (50.96)

22 (53.66)

54 (51.43)

21 (52.5)

64 (50.79)

11 (57.89)

54 (54)

21 (46.67)

 

> = median

51 (49.04)

19 (46.34)

51 (48.57)

19 (47.5)

62 (49.21)

8 (42.11)

46 (46)

24 (53.33)

L/CS Ratio

<median

50 (49.5)

21 (51.22)

50 (48.08)

21 (55.26)

62 (50.41)

9 (47.37)

51 (52.04)

20 (45.45)

 

> = median

51 (50.5)

20 (48.78)

54 (51.92)

17 (44.74)

61 (49.59)

10 (52.63)

47 (47.96)

24 (54.55)

Volume

<median

56 (53.85)

18 (43.9)

50 (47.62)

24 (60)

66 (52.38)

8 (42.11)

50 (50)

24 (53.33)

 

> = median

48 (46.15)

23 (56.1)

55 (52.38)

16 (40)

60 (47.62)

11 (57.89)

50 (50)

21 (46.67)